Corrigendum to "The prophylaxis and treatment potential of supplements for COVID-19" [Eur. J. Pharmacol. 887 (15 November 2020) 173530].

Sahebnasagh, Adeleh; Saghafi, Fatemeh; Avan, Razieh; Khoshi, Amirhosein; Khataminia, Masoud; Safdari, Mohammadreza; Habtemariam, Solomon; Ghaleno, Hassan Rezai; Nabavi, Seyed Mohammad.

Afiliação

Sahebnasagh A; Clinical Research Center, Department of Internal Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Saghafi F; Department of Clinical Pharmacy, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Avan R; Department of Clinical Pharmacy, Medical Toxicology and Drug Abuse Research Center (MTDRC), Faculty of Pharmacy, Birjand University of Medical Sciences, Birjand, Iran.
Khoshi A; Department of Clinical Biochemistry, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Khataminia M; Student Research Committee, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Safdari M; Department of Orthopedic Surgery, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Habtemariam S; Pharmacognosy Research Laboratories and Herbal Analysis Services UK, University of Greenwich, Central Avenue, Chatham-Maritime, Kent, ME4 4TB, United Kingdom.
Ghaleno HR; Department of Surgery, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Nabavi SM; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: nabavi208@gmail.com.

Eur J Pharmacol ; 972: 176571, 2024 Jun 05.

Article em En | MEDLINE | ID: mdl-38614058

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article